Clinical Trial Update: Artesunate Plus Amodiaquine in Malaria in Cote d'Ivoire [Phase 4]

View source ↗

Summary

A Sanofi-sponsored Phase 4 trial evaluating artesunate plus amodiaquine for malaria in Cote d'Ivoire has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• Amodiaquine (Amodiaquine)
• Artesunate (artesunate)

Snippet

Sponsor: Sanofi | Conditions: Malaria | Phase 4 | Status: COMPLETED